BusinessOrganovo Receives Orphan Designation From U.S. FDA for 3D Bioprinted Therapeutic Liver Tissue Treatment of Alpha-1 Antitrypsin DeficiencyBy Nasdaq OMXDec 26, 2017, 1:05 PM UTC
BusinessNewLink Genetics to Present at the 36th Annual J.P. Morgan Healthcare ConferenceBy Nasdaq OMXDec 21, 2017, 2:00 PM UTC
BusinessSchrödinger and MaRS Innovation Announce the Launch of Bright Angel TherapeuticsBy Nasdaq OMXDec 21, 2017, 1:00 PM UTC
BusinessHistogenics Corporation and MEDINET Co., Ltd Enter Into Licensing Agreement for Development and Commercialization of NeoCart for the Japanese MarketBy Nasdaq OMXDec 21, 2017, 11:00 AM UTC
BusinessKraig Biocraft Laboratories posts Holiday Letter to ShareholdersBy Nasdaq OMXDec 20, 2017, 10:30 PM UTC
BusinessAsklepion Pharmaceuticals Announces Special Protocol Assessment (SPA) Agreement with FDA for Phase 3 Program of Intravenous CitrullineBy Nasdaq OMXDec 19, 2017, 2:01 PM UTC
BusinessNew “Test and Treatment” Allergy Program Enables All Physicians To Provide Convenient And Effective Allergy CareBy Nasdaq OMXDec 19, 2017, 1:17 PM UTC
BusinessMyriad Genetics to Present at the 36th Annual J.P. Morgan Healthcare ConferenceBy Nasdaq OMXDec 19, 2017, 12:05 PM UTC
